Discriminative stimulus properties of mCPP: Evidence for a 5-HT(2C) receptor mode of action

Psychopharmacology

Volumn 137, Issue 3, 1998, Pages 292-302

  Gommans, Jan ^a   Hijzen, Theo H ^a   Maes, Robert A A ^a   Olivier, Berend ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

5 HT(2C); Drug discrimination; MCPP (m chlorophenylpiperazine); Rat

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (3 CHLOROPHENYL)BIGUANIDE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; CLONIDINE; ELTOPRAZINE; FENFLURAMINE; FLESINOXAN; HALOPERIDOL; IDAZOXAN; KETANSERIN; METERGOLINE; METHYSERGIDE; METITEPINE; MIANSERIN; QUIPAZINE; SEROTONIN 1B RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; TRAZODONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG MECHANISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN; DISCRIMINATION LEARNING; GENERALIZATION, STIMULUS; MALE; PIPERAZINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS;

EID: 0031809091     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050622     Document Type: Article

References (63)

1. 2 agonists in rats. Pharmacol Toxicol 64:165-172
2. Aulakh CS, Hill JL, Murphy DL (1992) Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats. J Pharmacol Exp Ther 263:588-595
3. Bagdy G, Calogero AE, Murphy DL, Szemeredi K (1989a) Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 125:2664-2669
4. Bagdy G, Szemeredi K, Kanyicska B, Murphy DL (1989b) Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats. J Pharmacol Exp Ther 250:72-78
5. Baumann MH, Rutter JJ, Auerbach SB (1993) Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats. Neuropharmacology 32:1381-1386
6. 2B) in rat stomach fundus longitudinal muscle. Br J Pharmacol 112:323-331
7. 1C-receptors in drug-induced penile erections in rats. Psychopharmacology 101:57-61
8. Boess FG, Martin IL (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33:275-317
9. Bourson A, Wanner D, Wyler R, Petit N, Zwingelstein C, Rudler A, Sleight AJ (1996) Pharmacological evaluation of the discriminative stimulus of metachlorophenylpiperazine. Pharmacol Biochem Behav 53:107-114
10. Caccia S, Ballabio M, Samanin R, Zanini MG, Garattini S (1981) (-)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. J Pharm Pharmacol 33:477-478
11. 2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP). Eur J Pharmacol 257: 27-38
12. Colpaert FC, Niemegeers CJE, Janssen PAJ (1982) A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. J Pharmacol Exp Ther 221:206-214
13. Conn PF, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1C) receptors. J Pharmacol Exp Ther 242:552-557
14. Cunningham KA, Callahan PM, Appel JB (1986) Discriminative stimulus properties of the serotonin agonist MK 212. Psychopharmacology 90:193-197
15. 2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine. Psychopharmacology 122: 237-243
16. 2C receptors in the stimulus effects of m-chlorophenylpiperazine. Psychopharmacology 119:222-230
17. Fiorella D, Rabin RA, Winter JC (1996) The interaction of clozapine with the meta-chlorophenylpiperazine (mCPP) discriminative stimulus. Life Sci 58:353-358
18. Fong MH, Garattini S, Caccia S (1982) 1-m-Chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazole. J Pharm Pharmacol 34:674-675
19. 2C receptors but not by sympathomimetic effects. Neuropharmacology 33:457-465
20. Glennon RA (1986) Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Life Sci 39:825-830
21. Glennon RA, Pierson ME, McKenney JD (1987) Stimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol, and mesulergine. Pharmacol Biochem Behav 29:197-199
22. 2 serotonin receptors: evidence for lack of selectivity. J Med Chem 35:734-740
23. Gommans J, Hijzen TH, Maes RA, Olivier B (1997) Discriminative stimulus properties of eltoprazine. Life Sci 61:11-19
24. 2A receptors expressed in fibroblasts. J Pharmacol Exp Ther 271:1122-1126
25. Hamick A, Peroutka SJ (1989) 1-( m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. Biol Psychiatry 25:569-575
26. 1C receptors in rat. FASEB J 6:A1869
27. Herndon JL, Pierson ME, Glennon RA (1992) Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine. Pharmacol Biochem Behav 43: 739-748
28. 3 receptor agonist 1-phenylbiguanide and m-chlorophenylbiguanide in rats. J Pharmacol Exp Ther 264:1440-1449
29. 1 recognition sites. J Recept Res 8:59-81
30. Hoyer D, Schoeffter P (1991) 5-HT receptors: subtypes and second messengers. J Recept Res 11:197-214
31. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonine). Pharmacol Rev 46: 157-203
32. Ireland SJ, Tyers MB (1987) Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br J Pharmacol 90:229-238
33. Järbe TUC (1987) Drug discrimination learning. In: Greenshaw AJ, Dourish CT (eds) Experimental psychopharmacology. Humana Press, Clifton New Jersey, pp 433-479
34. Kahn RS, Wetzler S (1991) m-Chlorophenylpiperazine as a probe of serotonergic function. Biol Psychiatry 30:1139-1166
35. Kennedy AJ, Gibson EL, O'Connell MT, Curzon G (1993) Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioral responses to mCPP. Psychopharmacology 113:262-268
36. 1C receptors. Br J Pharmacol 94:137-147
37. 1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. Br J Pharmacol 103:2016-2020
38. 1C receptor antagonists. Eur J Pharmacol 164:445-454
39. 2B receptor antagonist. Br J Pharmacol 111:797-802
40. Klodzińska A, Chojnacka-Wójcik E (1992) Hyperthermia induced by m-trifluoromethylphenylpiperazine (TFMPP) or m-chlorophenylpiperazine (m-CPP) in heat-adatpted rats. Psychopharmacology 109:466-472
41. Lucki I, Ward HR, Frazer A (1989) Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. J Pharmacol Exp Ther 249:155-164
42. Lucot JB (1984) Discriminative stimulus properties of MK-212 (6-chloro-2-(1-piperazinyl)-pyrazine). Fed Proc 43:745
43. Melzacka M, Boksa J, Maj J (1979) 1-(m-Chlorophenyl)piperazine: a metabolite of trazodone isolated from rat urine. J Pharm Pharmacol 31:855-856
44. Murphy DL, Lesch KP, Aulakh CS, Pigott, TA (1991) Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol Rev 43:527-552
45. Olivier B, Mos J, Raghoebar M, De Koning P, Mak M (1994) Serenics. Prog Drug Res 42:167-308
46. Pettibone DJ, Williams M (1984) Serotonin-releasing effects of substituted piperazines in vitro. Biochem Pharmacol 33:1531-1535
47. 1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats. Psychopharmacology 120:376-383
48. 3 receptors. Life Sci 50:599-605
49. 1B receptor activation. Pharmacol Biochem Behav 31:53-57
50. 1B receptor ligands exist? Naunyn-Schmiedeberg's Arch Pharmacol 339:675-683
51. Schreiber R, Brocco M, Millan MJ (1994) Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Eur J Pharmacol 264:99-102
52. Sills MA, Lucki I, Frazer A (1985) Development of selective tolerance to the behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP. Life Sci 36:2463-2469
53. Spanos LJ, Yamamoto BK (1989) Acute and subchronic effects of methylenedioxymethamphetamine [(+)-MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav 32:835-840
54. Stewart J, Badiani A (1993) Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4:289-312
55. Stewart BR, Jenner P, Marsden CD (1989) Induction of purposeless chewing behavior in rats by 5-HT agonist drugs. Eur J Pharmacol 162:101-107
56. Stolerman IP (1991) Measures of stimulus generalization in drug discrimination experiments. Behav Pharmacol 2:265-282
57. 2C/2B receptor agonist 1-(3-chlorophenyl)piperazine on glucose levels of rats. Eur J Pharmacol 307:75-80
58. 1A receptor. Eur J Pharmacol 133:47-56
59. Ulrichsen J, Partilla JS, Dax EM (1992) Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion. Psychopharmacology 107:229-235
60. White FJ, Appel JB (1981) A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine. Psychopharmacology 73:110-115
61. Whitton P, Curzon G (1990) Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus. Psychopharmacology 100:138-140
62. Winter JC, Rabin RA (1993) Discrimination stimulus properties of m-chlorophenylpiperazine. Pharmacol Biochem Behav 45: 221-223
63. Ybema CE, Slangen JL, Olivier B, Mos J (1993) Dose-dependent discriminative stimulus properties of 8-OH-DPAT. Behav Pharmacol 4:610-624